Wolverine Trading
LGND icon

Wolverine Trading’s Ligand Pharmaceuticals LGND Stock Holding History

Wolverine Trading’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,200
Closed -$214K – 5611
2024
Q3 		$214K Buy
+2,200
New +$221K ﹤0.01% 4019
2022
Q4 		– Sell
-9,618
Closed -$513K – 4568
2022
Q3 		$513K Buy
+9,618
New +$565K ﹤0.01% 2581
2022
Q1 		– Sell
-3,366
Closed -$328K – 5988
2021
Q4 		$328K Buy
+3,366
New +$311K ﹤0.01% 4025
2021
Q3 		– Sell
-2,725
Closed -$230K – 6646
2021
Q2 		$230K Buy
+2,725
New +$227K ﹤0.01% 4830
2020
Q1 		– Sell
-6,893
Closed -$447K – 4961
2019
Q4 		$447K Buy
6,893
+481
+8% +$32.1K ﹤0.01% 3178
2019
Q3 		$396K Buy
6,412
+641
+11% +$40.2K ﹤0.01% 2884
2019
Q2 		$411K Sell
5,771
-3,206
-36% -$236K ﹤0.01% 2924
2019
Q1 		$704K Sell
8,977
-55,303
-86% -$4.19M ﹤0.01% 2420
2018
Q4 		$5.45M Buy
+64,280
New +$6.85M 0.02% 760
2018
Q1 		– Sell
-2,725
Closed -$233K – 5498
2017
Q4 		$233K Sell
2,725
-2,405
-47% -$208K ﹤0.01% 3952
2017
Q3 		$436K Buy
+5,130
New +$406K ﹤0.01% 2774
2017
Q2 		– Sell
-15,549
Closed -$1.02M – 4662
2017
Q1 		$1.02M Buy
+15,549
New +$1.02M 0.01% 1700
2016
Q4 		– Sell
-46,808
Closed -$2.98M – 4822
2016
Q3 		$2.98M Buy
46,808
+31,419
+204% +$2.31M 0.01% 1044
2016
Q2 		$1.17M Buy
+15,389
New +$1.14M 0.01% 1476

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's LGND Position: Q2 2025 in Review

Wolverine Trading sold out of Ligand Pharmaceuticals (LGND) in Q2 2025, closing a stake of 1,974 shares — an estimated $212K sold.

Wolverine Trading first reported a position in LGND in Q4 2018 and held it in 7 quarters. The position peaked at $4.26M in Q1 2019. 271 funds tracked by Wall St. Rank hold LGND as of Q2 2025.

  • Wolverine Trading reported no remaining Ligand Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 1,974 Ligand Pharmaceuticals shares in Q2 2025, an estimated $212K.
  • Wolverine Trading first reported a position in Ligand Pharmaceuticals in Q4 2018 and held it in 7 quarters.
  • Wolverine Trading's Ligand Pharmaceuticals position peaked at $4.26M in Q1 2019.
  • 271 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.